Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. 1996

J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pennsylvania 15213, USA.

OBJECTIVE To determine whether serum levels of vascular permeability factor (VPF) are elevated in patients with ovarian hyperstimulation syndrome (OHSS) and to determine if luteinizing granulosa cells may be a source of VPF. METHODS Prospective observational study. METHODS University IVF and GIFT program. METHODS Eight consecutive IVF and GIFT patients at high risk for OHSS. METHODS Vascular permeability factor concentration in serum and follicular fluid. RESULTS Serum VPF was significantly higher (15.2 +/- 4.0 pM; mean +/- SEM) on day +14 in the group who developed severe OHSS compared with those who did not. Follicular fluid VPF (171.5 +/- 18.5 pM) was approximately 100-fold greater than serum (1.7 +/- 1.3 pM) or peritoneal fluid (2.5 +/- 1.3 pM) 36 hours after hCG administration. CONCLUSIONS Vascular permeability factor is elevated in patients with severe OHSS and the ovary may be a source of VPF secretion.

UI MeSH Term Description Entries
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
July 1994, Lancet (London, England),
J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
December 2002, Fertility and sterility,
J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
November 2001, Zhonghua fu chan ke za zhi,
J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
December 1998, The Journal of clinical investigation,
J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
January 2007, The Journal of clinical endocrinology and metabolism,
J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
November 2001, Zhonghua fu chan ke za zhi,
J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
June 1995, The Journal of clinical endocrinology and metabolism,
J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
January 2008, Human reproduction update,
J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
August 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
J S Krasnow, and S L Berga, and D S Guzick, and A J Zeleznik, and K T Yeo
April 2003, The Journal of reproductive medicine,
Copied contents to your clipboard!